Valuation: Roopa Industries Limited

Market Cap 308M 3.24M 2.81M 2.62M 2.41M 4.56M 4.61M 30.93M 12.09M 154M 12.17M 11.9M 511M P/E 2024
30.6x
P/E 2025 19.8x
Enterprise Value 607M 6.38M 5.54M 5.17M 4.75M 8.98M 9.08M 60.92M 23.81M 303M 23.97M 23.44M 1.01B EV / Sales 2024
0.97x
EV / Sales 2025 0.58x
Free-Float
36.13%
Yield 2024 *
-
Yield 2025 -
1 week-1.98%
Current month-0.04%
1 month-0.02%
3 months-15.29%
6 months+4.78%
Current year+13.49%
1 week 47.14
Extreme 47.14
52
1 month 40
Extreme 40
53.6
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 37.4
Extreme 37.4
114.9
5 years 12.9
Extreme 12.9
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 1997-12-31
Director of Finance/CFO - 2020-06-30
Compliance Officer - 2022-05-31
Director TitleAgeSince
Chairman 72 1997-12-31
Director/Board Member 70 1997-03-16
Director/Board Member 70 2015-11-02
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.98%-12.24%+19.00% 4.12M
-0.51%-8.60%+45.08%+148.21% 1T
+0.20%-4.42%+49.05%+50.81% 613B
-0.53%-7.37%+23.64%+65.03% 433B
+0.48%-2.77%+40.27%+34.96% 350B
+0.08%-4.45%+31.74%+39.89% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+2.94%-0.78%+29.17%+60.32% 204B
+3.13%+0.69%+18.11%+71.90% 163B
Average +1.06%-4.09%+22.85%+45.57% 350.05B
Weighted average by Cap. +0.72%-5.59%+33.88%+71.02%

Financials

2024 2025
Net sales 714M 7.5M 6.52M 6.08M 5.58M 10.56M 10.67M 71.63M 28M 357M 28.18M 27.56M 1.18B 1.21B 12.74M 11.06M 10.31M 9.47M 17.92M 18.11M 122M 47.53M 606M 47.84M 46.79M 2.01B
Net income 15.19M 160K 139K 129K 119K 225K 227K 1.52M 596K 7.59M 600K 587K 25.16M 20.35M 214K 186K 173K 159K 301K 304K 2.04M 798K 10.17M 803K 786K 33.7M
Net Debt 228M 2.39M 2.08M 1.94M 1.78M 3.37M 3.4M 22.85M 8.93M 114M 8.99M 8.79M 377M 299M 3.14M 2.73M 2.54M 2.34M 4.42M 4.47M 29.99M 11.72M 149M 11.8M 11.54M 495M
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
51
Date Price Change Volume
26-08-04 ₹49.98 0.00% 1
26-08-03 ₹49.98 -0.04% 538
26-07-31 ₹50.00 +4.12% 28
26-07-30 ₹48.02 -5.82% 199
26-07-28 ₹50.99 +2.49% 331
  1. Stock Market
  2. Stocks
  3. 530991 Stock